# Bowel Blockage Without a Block: Amyloidosis Presenting as Chronic Intestinal Pseudo-Obstruction

**Authors:** Rangesh Modi, Guy Nguefang, Freny Patel, Prince Modi, Edgar M Luna Landa

PMC · DOI: 10.7759/cureus.84189 · Cureus · 2025-05-15

## TL;DR

A man with chronic intestinal symptoms was diagnosed with amyloidosis after multiple surgeries and tests failed to find a cause.

## Contribution

This case highlights amyloidosis as a rare but important cause of chronic intestinal pseudo-obstruction.

## Key findings

- Chronic intestinal pseudo-obstruction was suspected after multiple surgeries failed to identify a cause.
- Amyloidosis was confirmed via abdominal fat pad biopsy with Congo red staining.
- The patient's symptoms partially improved with prucalopride but still require parenteral nutrition and a gastrostomy tube.

## Abstract

We present the case of a 61-year-old man with a history of schizophrenia and non-ischemic cardiomyopathy who was admitted with chronic nausea, vomiting, and abdominal pain. His clinical course was marked by recurrent hospitalizations due to persistently dilated small bowel and multiple exploratory laparotomies, all failing to yield a definitive diagnosis, raising suspicion for chronic intestinal pseudo-obstruction. Extensive testing for vascular, paraneoplastic, infectious, and autoimmune causes was unremarkable. Given his unexplained cardiomyopathy and elevated serum light chains with a mild M spike, amyloidosis was suspected. A biopsy of the abdominal fat pad with Congo red staining confirmed amyloid deposition. His symptoms showed partial improvement with prucalopride, but he continues to require total parenteral nutrition and a venting gastrostomy tube for symptom management. Amyloid subtyping and a bone marrow biopsy are pending to determine the underlying etiology.

## Linked entities

- **Chemicals:** prucalopride (PubChem CID 3052762)
- **Diseases:** schizophrenia (MONDO:0005090), amyloidosis (MONDO:0019065), chronic intestinal pseudo-obstruction (MONDO:0002803)

## Full-text entities

- **Genes:** HTR4 (5-hydroxytryptamine receptor 4) [NCBI Gene 3360] {aka 5-HT4, 5-HT4R}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, LOC102723407 (immunoglobulin heavy variable 4-38-2-like) [NCBI Gene 102723407] {aka IGHV4, IGHV4-30, IGHV4-38-2, IGHV4-39, IGHV4-b, IGVH4-39}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}
- **Diseases:** hormonal disorders (MESH:C565870), lung, breast, lymphoma (MESH:D061325), psychiatric illness (MESH:D001523), polyp (MESH:D011127), drug-induced (MESH:D000081015), thymoma (MESH:D013945), hypoproteinemia (MESH:D007019), GI dysmotility (MESH:D015154), monoclonal gammopathy (MESH:D010265), bleeding (MESH:D006470), normocytic anemia (MESH:D000740), lupus (MESH:D008180), systemic autoimmune disease (MESH:D020274), ischemic (MESH:D002545), ganglionitis (MESH:D045888), hypercalcemia (MESH:D006934), GI amyloid (MESH:D005767), dehydration (MESH:D003681), hepatitis (MESH:D056486), paraneoplastic (MESH:D010257), Amyloidosis (MESH:D000686), malnutrition (MESH:D044342), mechanical (MESH:D041781), AL amyloidosis (MESH:D000075363), cytomegalovirus (MESH:D003586), Ehlers-Danlos (MESH:D004535), cardiomegaly (MESH:D006332), myeloma (MESH:D009101), schizophrenia (MESH:D012559), myopathic (MESH:D009135), syphilis (MESH:D013587), abdominal cramping (MESH:D003085), Chagas (MESH:D014355), vascular stenosis (MESH:D003251), obstruction (MESH:D000402), narcotics (MESH:D000079524), Infectious (MESH:D003141), Guillain-Barre (MESH:D020275), infection (MESH:D007239), cardiomyopathy (MESH:D009202), non (MESH:C580335), cardiac dysfunction (MESH:D006331), Autoimmune (MESH:D001327), perforation (MESH:D057112), intestinal obstruction (MESH:D007415), pericardial effusion (MESH:D010490), abdominal pain (MESH:D015746), autoimmune myositis (MESH:D020721), neuropathic (MESH:D009437), metabolic alkalosis (MESH:D000471), nausea (MESH:D009325), myositis (MESH:D009220), dermato or polymyositis (MESH:D017285), inflammatory disorder (MESH:D007249), myasthenia gravis (MESH:D009157), GI bleeding (MESH:D006471), genetic neuropathies (MESH:D030342), atrophy (MESH:D001284), chronic intestinal failure (MESH:D000090124), bacterial (MESH:D001424)
- **Chemicals:** water (MESH:D014867), prucalopride (MESH:C406662), Congo red (MESH:D003224), metoclopramide (MESH:D008787), lactate (MESH:D019344), TB (MESH:D013725), barium (MESH:D001464), prokinetic agents (-), quetiapine (MESH:D000069348), opiates (MESH:D053610), thiamine (MESH:D013831), cortisol (MESH:D006854), folate (MESH:D005492), erythromycin (MESH:D004917), B12 (MESH:C034730), alcohol (MESH:D000438), glucose (MESH:D005947), clozapine (MESH:D003024), bilirubin (MESH:D001663), eosin (MESH:D004801)
- **Species:** Clostridioides difficile (species) [taxon 1496], Homo sapiens (human, species) [taxon 9606], Trypanosoma cruzi (species) [taxon 5693]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12081009/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12081009/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12081009/full.md

---
Source: https://tomesphere.com/paper/PMC12081009